The National Health Service (NHS) in England and Wales has approved the use of an injectable form of HIV pre-exposure prophylaxis (PrEP) developed by ViiV Healthcare,...
Insmed, a US-based biopharmaceutical firm, has officially launched its innovation centre at the Babraham Research Campus in Cambridge, UK, marking a significant step in its pursuit...
